In accordance with the booster interval recommendation change, MIIC now forecasts a booster dose of an mRNA COVID-19 vaccine five months after the date of the second dose. If you have any questions regarding the forecaster in MIIC, please contact the MIIC Help Desk at health.miichelp@state.mn.us.
As both the purple and gray cap vials of Comirnaty (Pfizer COVID-19 vaccine) are in circulation, double-check you are reporting the correct product information to MIIC. When incorrect information is entered into MIIC, patients may be unable to verify their status for work and other activities where vaccination is required. Entering data correctly saves time and improves our program’s ability to respond to vaccination gaps.
- When hand-entering doses directly in MIIC, verify you are selecting the correct trade name from the drop-down menu
- Select Comirnaty-PFR 30mcg for the purple cap formulation (required a diluent)
- Select Comirnaty-PFR t-s 30mcg for the gray cap formulation (does not require a diluent)
- When reporting immunizations via an HL7 interface (data flows from provider system to MIIC) or with the spreadsheet upload option, verify you are providing correct CPT/CVX code pairs for the vaccine formulation your organization is administering.
Vaccine type |
Trade name |
CPT |
CVX |
Purple cap (requires diluent) |
Comirnaty-PFR 30mcg |
91300 |
208 |
Gray cap (no diluent) |
Comirnaty-PFR t-s 30 mcg |
91305 |
217 |
If you have any questions regarding entering the correct product information into MIIC, please contact the MIIC Help Desk at health.miichelp@state.mn.us.
|